Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-10 Sale | 2024-04-12 4:02 pm | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | 5,714 | $40 | $228,560 | 53,171 (Direct) | View |
| 2024-04-03 Sale | 2024-04-05 9:32 pm | Vera Therapeutics Inc. | VERA | Grant Sean CHIEF FINANCIAL OFFICER | 118,477 | $39.58 | $4,689,722 | 151,509 (Indirect Direct) | View |
| 2024-03-21 Sale | 2024-03-25 9:46 pm | Vera Therapeutics Inc. | VERA | Katabi Maha Director | 834,459 | $40.86 | $34,099,583 | 2,793,987 (Indirect) | View |
| 2024-01-30 Purchase | 2024-02-01 5:58 pm | Vera Therapeutics Inc. | VERA | Katabi Maha Director | 161,290 | $31 | $4,999,990 | 3,628,446 (Indirect) | View |
| 2024-01-10 Sale | 2024-01-12 9:55 pm | Vera Therapeutics Inc. | VERA | COMMODORE CAPITAL LP 10% Owner | 1,050,000 | $18 | $18,900,000 | 4,400,000 (Indirect) | View |
| 2023-08-21 Sale | 2023-08-23 5:59 pm | Vera Therapeutics Inc. | VERA | Lin Celia Chief Medical Officer | 1,490 | $16.65 | $24,816 | 11,010 (Direct) | View |
| 2023-08-21 Sale | 2023-08-23 5:57 pm | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 1,490 | $16.66 | $24,817 | 26,962 (Direct) | View |
| 2023-08-21 Sale | 2023-08-23 5:56 pm | Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO | 5,210 | $16.66 | $86,779 | 243,361 (Direct) | View |
| 2023-06-23 Purchase | 2023-06-23 4:05 pm | Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer | 5,000 | $16.6 | $83,000 | 59,933 (Indirect Direct) | View |
| 2023-06-20 Purchase | 2023-06-22 4:10 pm | Vera Therapeutics Inc. | VERA | COMMODORE CAPITAL LP 10% Owner | 448,217 | $15.17 | $6,799,004 | 5,450,000 (Indirect) | View |
| 2023-03-30 Purchase | 2023-04-03 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 2,300 | $7.2395 | $16,651 | 1,949,295 (Indirect) | View |
| 2023-03-28 Purchase | 2023-03-30 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 23,908 | $7.2441 | $173,192 | 1,946,995 (Indirect) | View |
| 2023-03-24 Purchase | 2023-03-28 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 3,466 | $7.2424 | $25,102 | 1,923,087 (Indirect) | View |
| 2023-03-17 Purchase | 2023-03-21 4:40 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 89,297 | $7.1325 | $636,915 | 1,919,621 (Indirect) | View |
| 2023-03-15 Purchase | 2023-03-17 4:10 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 92,941 | $7.1043 | $660,278 | 1,830,324 (Indirect) | View |
| 2023-03-10 Purchase | 2023-03-14 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 48,003 | $7.1555 | $343,485 | 1,737,383 (Indirect) | View |
| 2023-03-03 Purchase | 2023-03-07 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 1,000 | $7.245 | $7,245 | 1,689,380 (Indirect) | View |
| 2023-03-01 Purchase | 2023-03-03 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 23,478 | $7.2428 | $170,047 | 1,688,380 (Indirect) | View |
| 2023-02-23 Purchase | 2023-02-27 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 200 | $7.235 | $1,447 | 1,664,902 (Indirect) | View |
| 2023-02-06 Purchase(A) | 2023-02-17 4:19 pm | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr | 5,714 | $7 | $39,998 | 22,679 (Direct) | View |
| 2023-02-06 Purchase(A) | 2023-02-17 4:17 pm | Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer | 14,285 | $7 | $99,995 | 49,933 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Exercise | 2024-04-05 9:32 pm | N/A 2031-07-12 | Vera Therapeutics Inc. | VERA | Grant Sean CHIEF FINANCIAL OFFICER | 99,828 | $0 | 151,509 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 9:32 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Grant Sean CHIEF FINANCIAL OFFICER | 99,828 | $14.87 | 151,509 (Direct) | View |
| 2023-03-14 Gift | 2024-04-05 9:27 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Grant Sean CHIEF FINANCIAL OFFICER | 16,541 | $0 | 41,276 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 4:54 pm | N/A 2034-01-15 | Vera Therapeutics Inc. | VERA | Fordyce Marshall PRESIDENT AND CEO | 371,250 | $0 | 628,127 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 4:06 pm | N/A 2034-01-15 | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | 103,125 | $0 | 138,304 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 4:03 pm | N/A 2034-01-15 | Vera Therapeutics Inc. | VERA | Grant Sean CHIEF FINANCIAL OFFICER | 123,750 | $0 | 186,183 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 4:05 pm | N/A 2034-01-04 | Vera Therapeutics Inc. | VERA | Turner William D. Chief Development Officer | 275,000 | $0 | 275,000 (Direct) | View |
Ownership | 2024-01-09 4:03 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Turner William D. Chief Development Officer | 0 | $0 | 0 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-08 08:17 am | N/A 2034-01-02 | Vera Therapeutics Inc. | VERA | Brenner Robert Chief Medical Officer | 350,000 | $0 | 350,000 (Direct) | View |
Ownership | 2024-01-08 08:15 am | N/A N/A | Vera Therapeutics Inc. | VERA | Brenner Robert Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
| 2023-12-29 Exercise | 2024-01-03 4:15 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO | 516 | $2.3174 | 1,131,089 (Direct) | View |
| 2023-12-29 Exercise | 2024-01-03 4:15 pm | N/A 2030-01-15 | Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO | 13,516 | $0 | 1,131,089 (Direct) | View |
| 2023-12-29 Exercise | 2024-01-03 4:15 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO | 13,000 | $2.8968 | 1,131,089 (Direct) | View |
| 2023-07-05 Exercise | 2023-07-06 4:05 pm | N/A 2031-04-13 | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr | 10,000 | $0 | 99,489 (Direct) | View |
| 2023-07-05 Exercise | 2023-07-06 4:05 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr | 10,000 | $3.9396 | 99,489 (Direct) | View |
Ownership | 2023-06-22 4:05 pm | N/A N/A | Vera Therapeutics Inc. | VERA | COMMODORE CAPITAL LP 10% Owner | 0 | $0 | 5,001,783 (Indirect) | View |
| 2023-05-10 Option Award | 2023-05-12 4:18 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:17 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | MORRISSEY MICHAEL Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:16 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Morrison Scott W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:14 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Katabi Maha Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:13 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Hall Kimball Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:12 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:11 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Cheng Andrew Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:14 pm | N/A 2033-02-14 | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr | 90,000 | $0 | 90,000 (Direct) | View |